Selected research
Market Outlook & Growth Opportunities
Global Cell and Gene Therapy Services Market Outlook and Growth Opportunities 2026
Market perspective
The global Cell and Gene Therapy Services market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.
The North America market for Cell and Gene Therapy Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Cell and Gene Therapy Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Cell and Gene Therapy Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
In China, the Cell and Gene Therapy Services market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Major global companies in the Cell and Gene Therapy Services market include BioIT Solutions, Lonza, SK pharmteco, Hypertrust, Qiagen, Bio-Techne, Promega, Tenthpin and Thermo Fisher, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.
This report provides an overview of the global Cell and Gene Therapy Services market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Cell and Gene Therapy Services and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Cell and Gene Therapy Services revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Cell and Gene Therapy Services market.
Cell and Gene Therapy Services Segment by Company
BioIT Solutions
Lonza
SK pharmteco
Hypertrust
Qiagen
Bio-Techne
Promega
Tenthpin
Thermo Fisher
Charles River
ACROBiosystems
Revvity
Pharmaron
Cell and Gene Therapy Services Segment by Type
Gene Therapy
Cell Therapy
Cell and Gene Therapy Services Segment by Application
Hospital
Clinic
Cell and Gene Therapy Services Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global Cell and Gene Therapy Services status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the Cell and Gene Therapy Services key companies, revenue, market share, and recent developments.
3. To split the Cell and Gene Therapy Services breakdown data by regions, type, companies, and application.
4. To analyze the global and key regions Cell and Gene Therapy Services market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Cell and Gene Therapy Services significant trends, drivers, influence factors in global and regions.
6. To analyze Cell and Gene Therapy Services competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cell and Gene Therapy Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Cell and Gene Therapy Services and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cell and Gene Therapy Services.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Cell and Gene Therapy Services industry.
Chapter 3: Detailed analysis of Cell and Gene Therapy Services company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales value of Cell and Gene Therapy Services in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.
Chapter 7: Sales value of Cell and Gene Therapy Services in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 9: Concluding Insights.
More report detail
Tables and figures
List of Tables
Table 1. Cell and Gene Therapy Services Industry Trends
Table 2. Cell and Gene Therapy Services Industry Drivers
Table 3. Cell and Gene Therapy Services Industry Opportunities and Challenges
Table 4. Cell and Gene Therapy Services Industry Restraints
Table 5. Global Cell and Gene Therapy Services Revenue by Company (US$ Million) & (2021-2026)
Table 6. Global Cell and Gene Therapy Services Revenue Share by Company (2021-2026)
Table 7. Global Cell and Gene Therapy Services Company Ranking, (2024-2026) & (US$ Million)
Table 8. Global Cell and Gene Therapy Services Key Company Manufacturing Base & Headquarters
Table 9. Global Cell and Gene Therapy Services Company, Product Type & Application
Table 10. Global Cell and Gene Therapy Services Company Establishment Date
Table 11. Global Company Market Concentration Ratio (CR5 and HHI)
Table 12. Global Cell and Gene Therapy Services by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025)
Table 13. Mergers & Acquisitions, Expansion
Table 14. Significant Companies of Gene Therapy
Table 15. Significant Companies of Cell Therapy
Table 16. Global Cell and Gene Therapy Services Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million)
Table 17. Global Cell and Gene Therapy Services Sales Value by Type (2021-2026) & (US$ Million)
Table 18. Global Cell and Gene Therapy Services Sales Value by Type (2027-2032) & (US$ Million)
Table 19. Global Cell and Gene Therapy Services Sales Value Share by Type (2021-2026)
Table 20. Global Cell and Gene Therapy Services Sales Value Share by Type (2027-2032)
Table 21. Significant Companies of Hospital
Table 22. Significant Companies of Clinic
Table 23. Global Cell and Gene Therapy Services Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million)
Table 24. Global Cell and Gene Therapy Services Sales Value by Application (2021-2026) & (US$ Million)
Table 25. Global Cell and Gene Therapy Services Sales Value by Application (2027-2032) & (US$ Million)
Table 26. Global Cell and Gene Therapy Services Sales Value Share by Application (2021-2026)
Table 27. Global Cell and Gene Therapy Services Sales Value Share by Application (2027-2032)
Table 28. Global Cell and Gene Therapy Services Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million)
Table 29. Global Cell and Gene Therapy Services Sales Value by Region (2021-2026) & (US$ Million)
Table 30. Global Cell and Gene Therapy Services Sales Value Share by Region (2021-2026)
Table 31. Global Cell and Gene Therapy Services Sales Value by Region (2027-2032) & (US$ Million)
Table 32. Global Cell and Gene Therapy Services Sales Value Share by Region (2027-2032)
Table 33. Global Cell and Gene Therapy Services Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 34. Global Cell and Gene Therapy Services Sales Value by Country (2021-2026) & (US$ Million)
Table 35. Global Cell and Gene Therapy Services Sales Value Market Share by Country (2021-2026)
Table 36. Global Cell and Gene Therapy Services Sales Value by Country (2027-2032) & (US$ Million)
Table 37. Global Cell and Gene Therapy Services Sales Value Market Share by Country (2027-2032)
Table 38. BioIT Solutions Company Information
Table 39. BioIT Solutions Business Overview
Table 40. BioIT Solutions Cell and Gene Therapy Services Revenue (US$ Million) and Gross Margin (2021-2026)
Table 41. BioIT Solutions Cell and Gene Therapy Services Product Portfolio
Table 42. BioIT Solutions Recent Development
Table 43. Lonza Company Information
Table 44. Lonza Business Overview
Table 45. Lonza Cell and Gene Therapy Services Revenue (US$ Million) and Gross Margin (2021-2026)
Table 46. Lonza Cell and Gene Therapy Services Product Portfolio
Table 47. Lonza Recent Development
Table 48. SK pharmteco Company Information
Table 49. SK pharmteco Business Overview
Table 50. SK pharmteco Cell and Gene Therapy Services Revenue (US$ Million) and Gross Margin (2021-2026)
Table 51. SK pharmteco Cell and Gene Therapy Services Product Portfolio
Table 52. SK pharmteco Recent Development
Table 53. Hypertrust Company Information
Table 54. Hypertrust Business Overview
Table 55. Hypertrust Cell and Gene Therapy Services Revenue (US$ Million) and Gross Margin (2021-2026)
Table 56. Hypertrust Cell and Gene Therapy Services Product Portfolio
Table 57. Hypertrust Recent Development
Table 58. Qiagen Company Information
Table 59. Qiagen Business Overview
Table 60. Qiagen Cell and Gene Therapy Services Revenue (US$ Million) and Gross Margin (2021-2026)
Table 61. Qiagen Cell and Gene Therapy Services Product Portfolio
Table 62. Qiagen Recent Development
Table 63. Bio-Techne Company Information
Table 64. Bio-Techne Business Overview
Table 65. Bio-Techne Cell and Gene Therapy Services Revenue (US$ Million) and Gross Margin (2021-2026)
Table 66. Bio-Techne Cell and Gene Therapy Services Product Portfolio
Table 67. Bio-Techne Recent Development
Table 68. Promega Company Information
Table 69. Promega Business Overview
Table 70. Promega Cell and Gene Therapy Services Revenue (US$ Million) and Gross Margin (2021-2026)
Table 71. Promega Cell and Gene Therapy Services Product Portfolio
Table 72. Promega Recent Development
Table 73. Tenthpin Company Information
Table 74. Tenthpin Business Overview
Table 75. Tenthpin Cell and Gene Therapy Services Revenue (US$ Million) and Gross Margin (2021-2026)
Table 76. Tenthpin Cell and Gene Therapy Services Product Portfolio
Table 77. Tenthpin Recent Development
Table 78. Thermo Fisher Company Information
Table 79. Thermo Fisher Business Overview
Table 80. Thermo Fisher Cell and Gene Therapy Services Revenue (US$ Million) and Gross Margin (2021-2026)
Table 81. Thermo Fisher Cell and Gene Therapy Services Product Portfolio
Table 82. Thermo Fisher Recent Development
Table 83. Charles River Company Information
Table 84. Charles River Business Overview
Table 85. Charles River Cell and Gene Therapy Services Revenue (US$ Million) and Gross Margin (2021-2026)
Table 86. Charles River Cell and Gene Therapy Services Product Portfolio
Table 87. Charles River Recent Development
Table 88. ACROBiosystems Company Information
Table 89. ACROBiosystems Business Overview
Table 90. ACROBiosystems Cell and Gene Therapy Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 91. ACROBiosystems Cell and Gene Therapy Services Product Portfolio
Table 92. ACROBiosystems Recent Development
Table 93. Revvity Company Information
Table 94. Revvity Business Overview
Table 95. Revvity Cell and Gene Therapy Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 96. Revvity Cell and Gene Therapy Services Product Portfolio
Table 97. Revvity Recent Development
Table 98. Pharmaron Company Information
Table 99. Pharmaron Business Overview
Table 100. Pharmaron Cell and Gene Therapy Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 101. Pharmaron Cell and Gene Therapy Services Product Portfolio
Table 102. Pharmaron Recent Development
Table 103. Research Programs/Design for This Report
Table 104. Authors List of This Report
Table 105. Secondary Sources
Table 106. Primary Sources
List of Figures
Figure 1. Cell and Gene Therapy Services Product Image
Figure 2. Global Cell and Gene Therapy Services Market Size (US$ Million), 2021 VS 2025 VS 2032
Figure 3. Global Cell and Gene Therapy Services Market Size (2021-2032) & (US$ Million)
Figure 4. Global Cell and Gene Therapy Services Company Revenue Ranking in 2025 (US$ Million)
Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million)
Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025
Figure 7. Gene Therapy Image
Figure 8. Cell Therapy Image
Figure 9. Global Cell and Gene Therapy Services Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million)
Figure 10. Global Cell and Gene Therapy Services Sales Value Share 2021 VS 2025 VS 2032
Figure 11. Global Cell and Gene Therapy Services Sales Value Share by Type (2021-2032)
Figure 12. Hospital Image
Figure 13. Clinic Image
Figure 14. Global Cell and Gene Therapy Services Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million)
Figure 15. Global Cell and Gene Therapy Services Sales Value Share 2021 VS 2025 VS 2032
Figure 16. Global Cell and Gene Therapy Services Sales Value Share by Application (2021-2032)
Figure 17. Global Cell and Gene Therapy Services Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million)
Figure 18. Global Cell and Gene Therapy Services Sales Value Share by Region: 2021 VS 2025 VS 2032
Figure 19. North America Cell and Gene Therapy Services Sales Value (2021-2032) & (US$ Million)
Figure 20. North America Cell and Gene Therapy Services Sales Value Share by Country (%), 2025 VS 2032
Figure 21. Europe Cell and Gene Therapy Services Sales Value (2021-2032) & (US$ Million)
Figure 22. Europe Cell and Gene Therapy Services Sales Value Share by Country (%), 2025 VS 2032
Figure 23. Asia-Pacific Cell and Gene Therapy Services Sales Value (2021-2032) & (US$ Million)
Figure 24. Asia-Pacific Cell and Gene Therapy Services Sales Value Share by Country (%), 2025 VS 2032
Figure 25. South America Cell and Gene Therapy Services Sales Value (2021-2032) & (US$ Million)
Figure 26. South America Cell and Gene Therapy Services Sales Value Share by Country (%), 2025 VS 2032
Figure 27. Middle East & Africa Cell and Gene Therapy Services Sales Value (2021-2032) & (US$ Million)
Figure 28. Middle East & Africa Cell and Gene Therapy Services Sales Value Share by Country (%), 2025 VS 2032
Figure 29. USA Cell and Gene Therapy Services Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 30. USA Cell and Gene Therapy Services Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 31. USA Cell and Gene Therapy Services Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 32. Canada Cell and Gene Therapy Services Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 33. Canada Cell and Gene Therapy Services Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 34. Canada Cell and Gene Therapy Services Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 35. Mexico Cell and Gene Therapy Services Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 36. Mexico Cell and Gene Therapy Services Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 37. Mexico Cell and Gene Therapy Services Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 38. Germany Cell and Gene Therapy Services Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 39. Germany Cell and Gene Therapy Services Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 40. Germany Cell and Gene Therapy Services Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 41. France Cell and Gene Therapy Services Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 42. France Cell and Gene Therapy Services Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 43. France Cell and Gene Therapy Services Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 44. U.K. Cell and Gene Therapy Services Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 45. U.K. Cell and Gene Therapy Services Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 46. U.K. Cell and Gene Therapy Services Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 47. Italy Cell and Gene Therapy Services Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 48. Italy Cell and Gene Therapy Services Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 49. Italy Cell and Gene Therapy Services Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 50. Spain Cell and Gene Therapy Services Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 51. Spain Cell and Gene Therapy Services Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 52. Spain Cell and Gene Therapy Services Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 53. Russia Cell and Gene Therapy Services Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 54. Russia Cell and Gene Therapy Services Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 55. Russia Cell and Gene Therapy Services Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 56. Netherlands Cell and Gene Therapy Services Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 57. Netherlands Cell and Gene Therapy Services Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 58. Netherlands Cell and Gene Therapy Services Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 59. Nordic Countries Cell and Gene Therapy Services Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 60. Nordic Countries Cell and Gene Therapy Services Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 61. Nordic Countries Cell and Gene Therapy Services Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 62. China Cell and Gene Therapy Services Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 63. China Cell and Gene Therapy Services Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 64. China Cell and Gene Therapy Services Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 65. Japan Cell and Gene Therapy Services Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 66. Japan Cell and Gene Therapy Services Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 67. Japan Cell and Gene Therapy Services Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 68. South Korea Cell and Gene Therapy Services Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 69. South Korea Cell and Gene Therapy Services Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 70. South Korea Cell and Gene Therapy Services Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 71. India Cell and Gene Therapy Services Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 72. India Cell and Gene Therapy Services Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 73. India Cell and Gene Therapy Services Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 74. Australia Cell and Gene Therapy Services Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 75. Australia Cell and Gene Therapy Services Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 76. Australia Cell and Gene Therapy Services Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 77. Southeast Asia Cell and Gene Therapy Services Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 78. Southeast Asia Cell and Gene Therapy Services Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 79. Southeast Asia Cell and Gene Therapy Services Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 80. Brazil Cell and Gene Therapy Services Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 81. Brazil Cell and Gene Therapy Services Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 82. Brazil Cell and Gene Therapy Services Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 83. Argentina Cell and Gene Therapy Services Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 84. Argentina Cell and Gene Therapy Services Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 85. Argentina Cell and Gene Therapy Services Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 86. Chile Cell and Gene Therapy Services Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 87. Chile Cell and Gene Therapy Services Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 88. Chile Cell and Gene Therapy Services Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 89. Colombia Cell and Gene Therapy Services Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 90. Colombia Cell and Gene Therapy Services Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 91. Colombia Cell and Gene Therapy Services Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 92. Peru Cell and Gene Therapy Services Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 93. Peru Cell and Gene Therapy Services Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 94. Peru Cell and Gene Therapy Services Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 95. Saudi Arabia Cell and Gene Therapy Services Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 96. Saudi Arabia Cell and Gene Therapy Services Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 97. Saudi Arabia Cell and Gene Therapy Services Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 98. Israel Cell and Gene Therapy Services Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 99. Israel Cell and Gene Therapy Services Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 100. Israel Cell and Gene Therapy Services Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 101. UAE Cell and Gene Therapy Services Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 102. UAE Cell and Gene Therapy Services Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 103. UAE Cell and Gene Therapy Services Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 104. Turkey Cell and Gene Therapy Services Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 105. Turkey Cell and Gene Therapy Services Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 106. Turkey Cell and Gene Therapy Services Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 107. Iran Cell and Gene Therapy Services Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 108. Iran Cell and Gene Therapy Services Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 109. Iran Cell and Gene Therapy Services Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 110. Egypt Cell and Gene Therapy Services Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 111. Egypt Cell and Gene Therapy Services Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 112. Egypt Cell and Gene Therapy Services Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 113. Years Considered
Figure 114. Research Process
Figure 115. Key Executives Interviewed
Scope & coverage.
Types
- Gene Therapy
- Cell Therapy
Applications
- Hospital
- Clinic
Companies covered
- BioIT Solutions
- Lonza
- SK pharmteco
- Hypertrust
- Qiagen
- Bio-Techne
- Promega
- Tenthpin
- Thermo Fisher
- Charles River
- ACROBiosystems
- Revvity
- Pharmaron
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Cell and Gene Therapy Services Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Cell and Gene Therapy Services Market Size (2021-2032)
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Cell and Gene Therapy Services Market Dynamics
- 2.1 Cell and Gene Therapy Services Industry Trends
- 2.2 Cell and Gene Therapy Services Industry Drivers
- 2.3 Cell and Gene Therapy Services Industry Opportunities and Challenges
- 2.4 Cell and Gene Therapy Services Industry Restraints
3 Cell and Gene Therapy Services Market by Company
- 3.1 Global Cell and Gene Therapy Services Company Revenue Ranking in 2025
- 3.2 Global Cell and Gene Therapy Services Revenue by Company (2021-2026)
- 3.3 Global Cell and Gene Therapy Services Company Ranking (2024-2026)
- 3.4 Global Cell and Gene Therapy Services Company Manufacturing Base and Headquarters
- 3.5 Global Cell and Gene Therapy Services Company Product Type and Application
- 3.6 Global Cell and Gene Therapy Services Company Establishment Date
- 3.7 Market Competitive Analysis
- 3.7.1 Global Cell and Gene Therapy Services Market Concentration Ratio (CR5 and HHI)
- 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.7.3 2025 Cell and Gene Therapy Services Tier 1, Tier 2, and Tier 3 Companies
- 3.8 Mergers and Acquisitions Expansion
4 Cell and Gene Therapy Services Market by Type
- 4.1 Cell and Gene Therapy Services Type Introduction
- 4.1.1 Gene Therapy
- 4.1.2 Cell Therapy
- 4.2 Global Cell and Gene Therapy Services Sales Value by Type
- 4.2.1 Global Cell and Gene Therapy Services Sales Value by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Cell and Gene Therapy Services Sales Value by Type (2021-2032)
- 4.2.3 Global Cell and Gene Therapy Services Sales Value Share by Type (2021-2032)
5 Cell and Gene Therapy Services Market by Application
- 5.1 Cell and Gene Therapy Services Application Introduction
- 5.1.1 Hospital
- 5.1.2 Clinic
- 5.2 Global Cell and Gene Therapy Services Sales Value by Application
- 5.2.1 Global Cell and Gene Therapy Services Sales Value by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Cell and Gene Therapy Services Sales Value by Application (2021-2032)
- 5.2.3 Global Cell and Gene Therapy Services Sales Value Share by Application (2021-2032)
6 Cell and Gene Therapy Services Regional Value Analysis
- 6.1 Global Cell and Gene Therapy Services Sales Value by Region: 2021 VS 2025 VS 2032
- 6.2 Global Cell and Gene Therapy Services Sales Value by Region (2021-2032)
- 6.2.1 Global Cell and Gene Therapy Services Sales Value by Region: 2021-2026
- 6.2.2 Global Cell and Gene Therapy Services Sales Value by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Cell and Gene Therapy Services Sales Value (2021-2032)
- 6.3.2 North America Cell and Gene Therapy Services Sales Value Share by Country, 2025 VS 2032
- 6.4 Europe
- 6.4.1 Europe Cell and Gene Therapy Services Sales Value (2021-2032)
- 6.4.2 Europe Cell and Gene Therapy Services Sales Value Share by Country, 2025 VS 2032
- 6.5 Asia-Pacific
- 6.5.1 Asia-Pacific Cell and Gene Therapy Services Sales Value (2021-2032)
- 6.5.2 Asia-Pacific Cell and Gene Therapy Services Sales Value Share by Country, 2025 VS 2032
- 6.6 South America
- 6.6.1 South America Cell and Gene Therapy Services Sales Value (2021-2032)
- 6.6.2 South America Cell and Gene Therapy Services Sales Value Share by Country, 2025 VS 2032
- 6.7 Middle East & Africa
- 6.7.1 Middle East & Africa Cell and Gene Therapy Services Sales Value (2021-2032)
- 6.7.2 Middle East & Africa Cell and Gene Therapy Services Sales Value Share by Country, 2025 VS 2032
7 Cell and Gene Therapy Services Country-level Value Analysis
- 7.1 Global Cell and Gene Therapy Services Sales Value by Country: 2021 VS 2025 VS 2032
- 7.2 Global Cell and Gene Therapy Services Sales Value by Country (2021-2032)
- 7.2.1 Global Cell and Gene Therapy Services Sales Value by Country (2021-2026)
- 7.2.2 Global Cell and Gene Therapy Services Sales Value by Country (2027-2032)
- 7.3 USA
- 7.3.1 USA Cell and Gene Therapy Services Sales Value Growth Rate (2021-2032)
- 7.3.2 USA Cell and Gene Therapy Services Sales Value Share by Type, 2025 VS 2032
- 7.3.3 USA Cell and Gene Therapy Services Sales Value Share by Application, 2025 VS 2032
- 7.4 Canada
- 7.4.1 Canada Cell and Gene Therapy Services Sales Value Growth Rate (2021-2032)
- 7.4.2 Canada Cell and Gene Therapy Services Sales Value Share by Type, 2025 VS 2032
- 7.4.3 Canada Cell and Gene Therapy Services Sales Value Share by Application, 2025 VS 2032
- 7.5 Mexico
- 7.5.1 Mexico Cell and Gene Therapy Services Sales Value Growth Rate (2021-2032)
- 7.5.2 Mexico Cell and Gene Therapy Services Sales Value Share by Type, 2025 VS 2032
- 7.5.3 Mexico Cell and Gene Therapy Services Sales Value Share by Application, 2025 VS 2032
- 7.6 Germany
- 7.6.1 Germany Cell and Gene Therapy Services Sales Value Growth Rate (2021-2032)
- 7.6.2 Germany Cell and Gene Therapy Services Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Germany Cell and Gene Therapy Services Sales Value Share by Application, 2025 VS 2032
- 7.7 France
- 7.7.1 France Cell and Gene Therapy Services Sales Value Growth Rate (2021-2032)
- 7.7.2 France Cell and Gene Therapy Services Sales Value Share by Type, 2025 VS 2032
- 7.7.3 France Cell and Gene Therapy Services Sales Value Share by Application, 2025 VS 2032
- 7.8 U.K.
- 7.8.1 U.K. Cell and Gene Therapy Services Sales Value Growth Rate (2021-2032)
- 7.8.2 U.K. Cell and Gene Therapy Services Sales Value Share by Type, 2025 VS 2032
- 7.8.3 U.K. Cell and Gene Therapy Services Sales Value Share by Application, 2025 VS 2032
- 7.9 Italy
- 7.9.1 Italy Cell and Gene Therapy Services Sales Value Growth Rate (2021-2032)
- 7.9.2 Italy Cell and Gene Therapy Services Sales Value Share by Type, 2025 VS 2032
- 7.9.3 Italy Cell and Gene Therapy Services Sales Value Share by Application, 2025 VS 2032
- 7.10 Spain
- 7.10.1 Spain Cell and Gene Therapy Services Sales Value Growth Rate (2021-2032)
- 7.10.2 Spain Cell and Gene Therapy Services Sales Value Share by Type, 2025 VS 2032
- 7.10.3 Spain Cell and Gene Therapy Services Sales Value Share by Application, 2025 VS 2032
- 7.11 Russia
- 7.11.1 Russia Cell and Gene Therapy Services Sales Value Growth Rate (2021-2032)
- 7.11.2 Russia Cell and Gene Therapy Services Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Russia Cell and Gene Therapy Services Sales Value Share by Application, 2025 VS 2032
- 7.12 Netherlands
- 7.12.1 Netherlands Cell and Gene Therapy Services Sales Value Growth Rate (2021-2032)
- 7.12.2 Netherlands Cell and Gene Therapy Services Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Netherlands Cell and Gene Therapy Services Sales Value Share by Application, 2025 VS 2032
- 7.13 Nordic Countries
- 7.13.1 Nordic Countries Cell and Gene Therapy Services Sales Value Growth Rate (2021-2032)
- 7.13.2 Nordic Countries Cell and Gene Therapy Services Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Nordic Countries Cell and Gene Therapy Services Sales Value Share by Application, 2025 VS 2032
- 7.14 China
- 7.14.1 China Cell and Gene Therapy Services Sales Value Growth Rate (2021-2032)
- 7.14.2 China Cell and Gene Therapy Services Sales Value Share by Type, 2025 VS 2032
- 7.14.3 China Cell and Gene Therapy Services Sales Value Share by Application, 2025 VS 2032
- 7.15 Japan
- 7.15.1 Japan Cell and Gene Therapy Services Sales Value Growth Rate (2021-2032)
- 7.15.2 Japan Cell and Gene Therapy Services Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Japan Cell and Gene Therapy Services Sales Value Share by Application, 2025 VS 2032
- 7.16 South Korea
- 7.16.1 South Korea Cell and Gene Therapy Services Sales Value Growth Rate (2021-2032)
- 7.16.2 South Korea Cell and Gene Therapy Services Sales Value Share by Type, 2025 VS 2032
- 7.16.3 South Korea Cell and Gene Therapy Services Sales Value Share by Application, 2025 VS 2032
- 7.17 India
- 7.17.1 India Cell and Gene Therapy Services Sales Value Growth Rate (2021-2032)
- 7.17.2 India Cell and Gene Therapy Services Sales Value Share by Type, 2025 VS 2032
- 7.17.3 India Cell and Gene Therapy Services Sales Value Share by Application, 2025 VS 2032
- 7.18 Australia
- 7.18.1 Australia Cell and Gene Therapy Services Sales Value Growth Rate (2021-2032)
- 7.18.2 Australia Cell and Gene Therapy Services Sales Value Share by Type, 2025 VS 2032
- 7.18.3 Australia Cell and Gene Therapy Services Sales Value Share by Application, 2025 VS 2032
- 7.19 Southeast Asia
- 7.19.1 Southeast Asia Cell and Gene Therapy Services Sales Value Growth Rate (2021-2032)
- 7.19.2 Southeast Asia Cell and Gene Therapy Services Sales Value Share by Type, 2025 VS 2032
- 7.19.3 Southeast Asia Cell and Gene Therapy Services Sales Value Share by Application, 2025 VS 2032
- 7.20 Brazil
- 7.20.1 Brazil Cell and Gene Therapy Services Sales Value Growth Rate (2021-2032)
- 7.20.2 Brazil Cell and Gene Therapy Services Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Brazil Cell and Gene Therapy Services Sales Value Share by Application, 2025 VS 2032
- 7.21 Argentina
- 7.21.1 Argentina Cell and Gene Therapy Services Sales Value Growth Rate (2021-2032)
- 7.21.2 Argentina Cell and Gene Therapy Services Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Argentina Cell and Gene Therapy Services Sales Value Share by Application, 2025 VS 2032
- 7.22 Chile
- 7.22.1 Chile Cell and Gene Therapy Services Sales Value Growth Rate (2021-2032)
- 7.22.2 Chile Cell and Gene Therapy Services Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Chile Cell and Gene Therapy Services Sales Value Share by Application, 2025 VS 2032
- 7.23 Colombia
- 7.23.1 Colombia Cell and Gene Therapy Services Sales Value Growth Rate (2021-2032)
- 7.23.2 Colombia Cell and Gene Therapy Services Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Colombia Cell and Gene Therapy Services Sales Value Share by Application, 2025 VS 2032
- 7.24 Peru
- 7.24.1 Peru Cell and Gene Therapy Services Sales Value Growth Rate (2021-2032)
- 7.24.2 Peru Cell and Gene Therapy Services Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Peru Cell and Gene Therapy Services Sales Value Share by Application, 2025 VS 2032
- 7.25 Saudi Arabia
- 7.25.1 Saudi Arabia Cell and Gene Therapy Services Sales Value Growth Rate (2021-2032)
- 7.25.2 Saudi Arabia Cell and Gene Therapy Services Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Saudi Arabia Cell and Gene Therapy Services Sales Value Share by Application, 2025 VS 2032
- 7.26 Israel
- 7.26.1 Israel Cell and Gene Therapy Services Sales Value Growth Rate (2021-2032)
- 7.26.2 Israel Cell and Gene Therapy Services Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Israel Cell and Gene Therapy Services Sales Value Share by Application, 2025 VS 2032
- 7.27 UAE
- 7.27.1 UAE Cell and Gene Therapy Services Sales Value Growth Rate (2021-2032)
- 7.27.2 UAE Cell and Gene Therapy Services Sales Value Share by Type, 2025 VS 2032
- 7.27.3 UAE Cell and Gene Therapy Services Sales Value Share by Application, 2025 VS 2032
- 7.28 Turkey
- 7.28.1 Turkey Cell and Gene Therapy Services Sales Value Growth Rate (2021-2032)
- 7.28.2 Turkey Cell and Gene Therapy Services Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Turkey Cell and Gene Therapy Services Sales Value Share by Application, 2025 VS 2032
- 7.29 Iran
- 7.29.1 Iran Cell and Gene Therapy Services Sales Value Growth Rate (2021-2032)
- 7.29.2 Iran Cell and Gene Therapy Services Sales Value Share by Type, 2025 VS 2032
- 7.29.3 Iran Cell and Gene Therapy Services Sales Value Share by Application, 2025 VS 2032
- 7.30 Egypt
- 7.30.1 Egypt Cell and Gene Therapy Services Sales Value Growth Rate (2021-2032)
- 7.30.2 Egypt Cell and Gene Therapy Services Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Egypt Cell and Gene Therapy Services Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 BioIT Solutions
- 8.1.1 BioIT Solutions Company Information
- 8.1.2 BioIT Solutions Business Overview
- 8.1.3 BioIT Solutions Cell and Gene Therapy Services Revenue and Gross Margin (2021-2026)
- 8.1.4 BioIT Solutions Cell and Gene Therapy Services Product Portfolio
- 8.1.5 BioIT Solutions Recent Developments
- 8.2 Lonza
- 8.2.1 Lonza Company Information
- 8.2.2 Lonza Business Overview
- 8.2.3 Lonza Cell and Gene Therapy Services Revenue and Gross Margin (2021-2026)
- 8.2.4 Lonza Cell and Gene Therapy Services Product Portfolio
- 8.2.5 Lonza Recent Developments
- 8.3 SK pharmteco
- 8.3.1 SK pharmteco Company Information
- 8.3.2 SK pharmteco Business Overview
- 8.3.3 SK pharmteco Cell and Gene Therapy Services Revenue and Gross Margin (2021-2026)
- 8.3.4 SK pharmteco Cell and Gene Therapy Services Product Portfolio
- 8.3.5 SK pharmteco Recent Developments
- 8.4 Hypertrust
- 8.4.1 Hypertrust Company Information
- 8.4.2 Hypertrust Business Overview
- 8.4.3 Hypertrust Cell and Gene Therapy Services Revenue and Gross Margin (2021-2026)
- 8.4.4 Hypertrust Cell and Gene Therapy Services Product Portfolio
- 8.4.5 Hypertrust Recent Developments
- 8.5 Qiagen
- 8.5.1 Qiagen Company Information
- 8.5.2 Qiagen Business Overview
- 8.5.3 Qiagen Cell and Gene Therapy Services Revenue and Gross Margin (2021-2026)
- 8.5.4 Qiagen Cell and Gene Therapy Services Product Portfolio
- 8.5.5 Qiagen Recent Developments
- 8.6 Bio-Techne
- 8.6.1 Bio-Techne Company Information
- 8.6.2 Bio-Techne Business Overview
- 8.6.3 Bio-Techne Cell and Gene Therapy Services Revenue and Gross Margin (2021-2026)
- 8.6.4 Bio-Techne Cell and Gene Therapy Services Product Portfolio
- 8.6.5 Bio-Techne Recent Developments
- 8.7 Promega
- 8.7.1 Promega Company Information
- 8.7.2 Promega Business Overview
- 8.7.3 Promega Cell and Gene Therapy Services Revenue and Gross Margin (2021-2026)
- 8.7.4 Promega Cell and Gene Therapy Services Product Portfolio
- 8.7.5 Promega Recent Developments
- 8.8 Tenthpin
- 8.8.1 Tenthpin Company Information
- 8.8.2 Tenthpin Business Overview
- 8.8.3 Tenthpin Cell and Gene Therapy Services Revenue and Gross Margin (2021-2026)
- 8.8.4 Tenthpin Cell and Gene Therapy Services Product Portfolio
- 8.8.5 Tenthpin Recent Developments
- 8.9 Thermo Fisher
- 8.9.1 Thermo Fisher Company Information
- 8.9.2 Thermo Fisher Business Overview
- 8.9.3 Thermo Fisher Cell and Gene Therapy Services Revenue and Gross Margin (2021-2026)
- 8.9.4 Thermo Fisher Cell and Gene Therapy Services Product Portfolio
- 8.9.5 Thermo Fisher Recent Developments
- 8.10 Charles River
- 8.10.1 Charles River Company Information
- 8.10.2 Charles River Business Overview
- 8.10.3 Charles River Cell and Gene Therapy Services Revenue and Gross Margin (2021-2026)
- 8.10.4 Charles River Cell and Gene Therapy Services Product Portfolio
- 8.10.5 Charles River Recent Developments
- 8.11 ACROBiosystems
- 8.11.1 ACROBiosystems Company Information
- 8.11.2 ACROBiosystems Business Overview
- 8.11.3 ACROBiosystems Cell and Gene Therapy Services Revenue and Gross Margin (2021-2026)
- 8.11.4 ACROBiosystems Cell and Gene Therapy Services Product Portfolio
- 8.11.5 ACROBiosystems Recent Developments
- 8.12 Revvity
- 8.12.1 Revvity Company Information
- 8.12.2 Revvity Business Overview
- 8.12.3 Revvity Cell and Gene Therapy Services Revenue and Gross Margin (2021-2026)
- 8.12.4 Revvity Cell and Gene Therapy Services Product Portfolio
- 8.12.5 Revvity Recent Developments
- 8.13 Pharmaron
- 8.13.1 Pharmaron Company Information
- 8.13.2 Pharmaron Business Overview
- 8.13.3 Pharmaron Cell and Gene Therapy Services Revenue and Gross Margin (2021-2026)
- 8.13.4 Pharmaron Cell and Gene Therapy Services Product Portfolio
- 8.13.5 Pharmaron Recent Developments
9 Concluding Insights
10 Appendix
- 10.1 Reasons for Doing This Study
- 10.2 Research Methodology
- 10.3 Research Process
- 10.4 Authors List of This Report
- 10.5 Data Source
- 10.5.1 Secondary Sources
- 10.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
$4,250USD
Buy nowPDF by email within 3–5 working days after payment confirmation.
Talk to an analyst